Page last updated: 2024-10-21

1-anilino-8-naphthalenesulfonate and Inappropriate GH Secretion Syndrome (Acromegaly)

1-anilino-8-naphthalenesulfonate has been researched along with Inappropriate GH Secretion Syndrome (Acromegaly) in 4 studies

1-anilino-8-naphthalenesulfonate: RN given refers to parent cpd
8-anilinonaphthalene-1-sulfonic acid : A naphthalenesulfonic acid that is naphthalene-1-sulfonic acid substituted by a phenylamino group at position 8.

Research Excerpts

ExcerptRelevanceReference
"Objectives The aim of the study was to evaluate circulating insulin-like growth factor-1 (IGF-1), feline pancreas-specific lipase (fPLI) and total thyroxine (TT4) concentrations and urinary corticoid-to-creatinine ratio (UCCR) as indicators for the prevalence of acromegaly, pancreatitis, hyperthyroidism and hypercortisolism in cats with diabetes mellitus."7.85Evaluation of insulin-like growth factor-1, total thyroxine, feline pancreas-specific lipase and urinary corticoid-to-creatinine ratio in cats with diabetes mellitus in Switzerland and the Netherlands. ( Kooistra, HS; Prins, M; Reusch, CE; Riond, B; Schaefer, S; Steiner, JM; Suchodolski, JS; Zini, E, 2017)
"Objectives The aim of the study was to evaluate circulating insulin-like growth factor-1 (IGF-1), feline pancreas-specific lipase (fPLI) and total thyroxine (TT4) concentrations and urinary corticoid-to-creatinine ratio (UCCR) as indicators for the prevalence of acromegaly, pancreatitis, hyperthyroidism and hypercortisolism in cats with diabetes mellitus."3.85Evaluation of insulin-like growth factor-1, total thyroxine, feline pancreas-specific lipase and urinary corticoid-to-creatinine ratio in cats with diabetes mellitus in Switzerland and the Netherlands. ( Kooistra, HS; Prins, M; Reusch, CE; Riond, B; Schaefer, S; Steiner, JM; Suchodolski, JS; Zini, E, 2017)
"Gross hyperlipidemia revealed type V hyperlipoproteininemia, according to agarose gel electrophoretic pattern of serum lipoprotein."1.26Secondary type V hyperlipoproteinemia in an acromegalic patient without overt diabetes. ( Haba, T; Kawato, M; Mabuchi, H; Nakabayashi, H; Takeda, R; Tatami, R; Ueda, K, 1982)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19902 (50.00)18.7374
1990's1 (25.00)18.2507
2000's0 (0.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Schaefer, S1
Kooistra, HS1
Riond, B1
Suchodolski, JS1
Steiner, JM1
Prins, M1
Zini, E1
Reusch, CE1
Murase, T1
Yamada, N1
Ohsawa, N1
Kosaka, K1
Morita, S1
Yoshida, S1
Takeda, R1
Tatami, R1
Ueda, K1
Haba, T1
Kawato, M1
Nakabayashi, H1
Mabuchi, H1
Tan, KC1
Shiu, SW1
Janus, ED1
Lam, KS1

Other Studies

4 other studies available for 1-anilino-8-naphthalenesulfonate and Inappropriate GH Secretion Syndrome (Acromegaly)

ArticleYear
Evaluation of insulin-like growth factor-1, total thyroxine, feline pancreas-specific lipase and urinary corticoid-to-creatinine ratio in cats with diabetes mellitus in Switzerland and the Netherlands.
    Journal of feline medicine and surgery, 2017, Volume: 19, Issue:8

    Topics: Acromegaly; Adrenal Cortex Hormones; Animals; Cat Diseases; Cats; Creatinine; Cushing Syndrome; Diab

2017
Decline of postheparin plasma lipoprotein lipase in acromegalic patients.
    Metabolism: clinical and experimental, 1980, Volume: 29, Issue:7

    Topics: Acromegaly; Adult; Blood Glucose; Cholesterol; Female; Growth Hormone; Heparin; Humans; Insulin; Kin

1980
Secondary type V hyperlipoproteinemia in an acromegalic patient without overt diabetes.
    Endokrinologie, 1982, Volume: 79, Issue:1

    Topics: Acromegaly; Adult; Cholesterol; Growth Hormone; Hormones; Humans; Hyperlipidemias; Hyperlipoproteine

1982
LDL subfractions in acromegaly: relation to growth hormone and insulin-like growth factor-I.
    Atherosclerosis, 1997, Feb-28, Volume: 129, Issue:1

    Topics: Acromegaly; Apolipoproteins; Biomarkers; Body Mass Index; Bromocriptine; Carrier Proteins; Cholester

1997